Doxorubicin-Trabectedin Impresses in Leiomyosarcoma

(MedPage Today) -- The combination of doxorubicin and trabectedin (Yondelis) continued to show encouraging activity as first-line treatment of patients with metastatic or unresectable leiomyosarcoma (LMS), according to results from the phase III...